Offer - Urjas Oil for just ₹ 1 X
Combihale FF 250 Inhaler is a prescription drug, available for use as Inhaler. Combihale FF 250 Inhaler also has some secondary and off-label uses. These are listed below.
The correct dosage of Combihale FF 250 Inhaler depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Combihale FF 250 Inhaler include Nosebleed, Chest tightness, Cough. Besides the aforementioned side effects, there are other adverse effects of Combihale FF 250 Inhaler as well, which are listed below. Usually, these side effects of Combihale FF 250 Inhaler go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Combihale FF 250 Inhaler is Moderate for pregnant women and Mild for women who are breastfeeding. Warnings related to Combihale FF 250 Inhaler's effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Combihale FF 250 Inhaler are listed in the contraindications section below.
Additionally, Combihale FF 250 Inhaler may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Combihale FF 250 Inhaler is safe while driving, and is is addictive in nature.
Combihale FF 250 Inhaler is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Combihale FF 250 Inhaler safe for pregnant women?
Combihale FF may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Combihale FF again without your doctor's advice.
Is the use of Combihale FF 250 Inhaler safe during breastfeeding?
Side effects of Combihale FF on breastfeeding women are very mild.
What is the effect of Combihale FF 250 Inhaler on the Kidneys?
Using Combihale FF does not have any harmful effects on kidneys.
What is the effect of Combihale FF 250 Inhaler on the Liver?
There may be an adverse effect on the liver after taking Combihale FF. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Combihale FF 250 Inhaler on the Heart?
Combihale FF can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Combihale FF 250 Inhaler unless your doctor advises you to do so -
Is this Combihale FF 250 Inhaler habit forming or addictive?
No, there is no any evidence that Combihale FF 250 Inhaler is addictive.
Interaction between Food and Combihale FF 250 Inhaler
There isn't any research available on the side effects of taking Combihale FF 250 Inhaler with food.
Interaction between Alcohol and Combihale FF 250 Inhaler
Due to lack of research, there is no information about the side effects of taking Combihale FF 250 Inhaler with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359